Portefeuille de l'ETF PTH (NASDAQ) | MetaTrader

Afficher le graphique complet

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

Invesco Private Prime Fund 48.91 M 48.91 M 20.79%

Invesco Private Government Fund 16.08 M 16.08 M 6.83%

GH Guardant Health, Inc. 11.70 M 72.20 K 4.97%

ROIV Roivant Sciences Ltd. 11.63 M 343.02 K 4.95%

RVMD Revolution Medicines, Inc. 11.61 M 61.93 K 4.94%

AXSM Axsome Therapeutics, Inc. 9.70 M 44.49 K 4.12%

BTSG BrightSpring Health Services, Inc. 9.48 M 158.70 K 4.03%

LQDA Liquidia Corp. 7.08 M 84.23 K 3.01%

ERAS Erasca, Inc. 6.92 M 381.02 K 2.94%

ORKA Oruka Therapeutics, Inc. 6.44 M 66.72 K 2.74%

TXG 10x Genomics, Inc. 5.34 M 112.98 K 2.27%

RLAY Relay Therapeutics, Inc. 5.29 M 280.76 K 2.25%

TNGX Tango Therapeutics Inc. 5.07 M 186.71 K 2.16%

TVTX Travere Therapeutics, Inc. 5.07 M 90.74 K 2.16%

OSCR Oscar Health, Inc. 4.93 M 158.06 K 2.10%

ILMN Illumina, Inc. 4.89 M 23.86 K 2.08%

AGL agilon health, Inc. 4.86 M 53.03 K 2.07%

AXGN Axogen, Inc. 4.84 M 114.69 K 2.06%

ARWR Arrowhead Pharmaceuticals, Inc. 4.74 M 55.98 K 2.01%

SYRE Spyre Therapeutics, Inc. 4.73 M 48.13 K 2.01%

1
2
3

Nouvelles

Moderna fait progresser le vaccin contre Ebola vers les tests sur l'homme | Benzinga France

Le juge accorde à Natera une redevance continue de 30 % dans la bataille de brevets sur le MRD | Benzinga France